Cayman

cGAS (161-522) (human recombinant)

CHF 656.00
In stock
CAY-25001-100100 µgCHF 656.00
 
More Information
Product Details
Synonyms 2'3'-cGAMP Synthase; C6orf150; cGAMP Synthase; Cyclic GMP-AMP Synthase; h-cGAS; Mab-21 domain-containing protein 1; MB21D1
Product Type Protein
Properties
Sequence N-terminal histidine-tagged human cGAS protein (truncated), purified from E. coli.
Purity ≥90% (SDS-PAGE)
Formulation 50 mM HEPES, pH 8.0, 150 mM sodium chloride, 1 mM DTT, and 10% glycerol
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Cayman Chemicals.
Shipping and Handling
Shipping DRY ICE
Long Term Storage -80°C
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description
Cyclic GMP-AMP (cGAMP) synthase (cGAS) (161-522) is a truncated form of cGAS that contains the nucleotidyltransferase and Mab21 domains. cGAS is a nucleotidyltransferase located in the cytosol that acts as a cytosolic DNA sensor to detect foreign DNA from microbial pathogens as part of the innate immune response. Upon binding to cytosolic DNA, cGAS produces the cyclic dinucleotide second messenger cGAMP, which activates stimulator of interferon genes (STING), leading to activation of the type I interferon (IFN) pathway. In vitro, fibroblasts, macrophages, and dendritic cells isolated from cGAS knockout (cGAS-/-) mice do not produce type I IFNs following DNA transfection or DNA virus infection. Similarly, cells containing a frame-shift mutation in the cGAS locus fail to mount an immune response to HIV and other retroviruses. In vivo, cGAS-/- mice infected with herpes simplex virus 1 (HSV-1) have lower levels of IFN-α and IFN-β, shorter survival times, and higher post-mortem levels of HSV-1 in the brain.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.